According to the study, there is a J-shaped curve in which too little or too much sodium excretion can increase risk of adverse cardiovascular events.
A new study published in the Journal of the American Medical Association examining the effects of sodium and potassium levels on cardiovascular disease risk says there is a J-shaped curve in which too little or too much sodium excretion can increase risk of adverse cardiovascular events. The Salt Institute has commented on the study, saying that it is evidence that the low-sodium diet being promoted by the new Dietary Guidelines for Americans is dangerous.
The study examined data from 28,880 subjects in the ONTARGET and TRANSCEND trials that took place between November 2001 and March 2008. Researchers say that a sodium excretion of more than 7 g/day was associated with increased risk of cardiovascular events, while sodium excretion of less than 3 g/day was also associated with increased risk. Excretion levels between 4 to 5.99 g/day, however, did not show increased risk.
By contrast, the Dietary Guidelines for Americans recommends a daily sodium intake of only 1500 to 2300 mg/day.
Commenting on the study, Salt Institute president Lori Roman stated, “I find it incredible that at the very time that the overwhelming mass of evidence is cautioning us against population-wide salt reduction, the government is moving full-steam ahead with this risky experiment on its citizens.”
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.